PATENT CLAIM ANALYSIS

Application Number: 15911567
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "303000"]

Abstract:
The invention is a method of treating osteoarthritis or normalizing a condition of osteoarthritis comprising administering to an animal or a human in need thereof a therapeutically effective amount of 3-[2-(4-{2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl}phenyl)ethyl]-1-[(4-methylbenzene)sulfonyl]urea or a pharmaceutically acceptable salt thereof.

Claim (Index 12):
The method according to  claim 11 , wherein the one or more additional compounds known to be useful in the treatment or prevention of the cartilage disease or the symptom thereof is selected from the group consisting of an NSAID, a COX-2 inhibitor, a steroid, a matrix metalloproteinase inhibitor and hyaluronic acid.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 90.0
- Lexical Diversity: 1.35556
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13580323', '10771696', '12843348', '12515354', '12316343']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7980671218470959
- 35 USC 102 Novelty (BERT): 0.5654738719430452
- Combined Prediction Score: 0.7748077968566909
- Mean Citation Score: 353.931818
- Max Citation Score: 496.591
- Similarity Product: 304.9347083116174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test